Cargando…
Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management
As of April 21, 2020, more than 2.5 million cases of coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, have been reported in 210 countries and territories, with the death toll at 171,810. Both chloroquine and hydroxychloroquine have gained considerable media attention as possible...
Autores principales: | Lebin, Jacob A., LeSaint, Kathy T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Department of Emergency Medicine, University of California, Irvine School of Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390560/ https://www.ncbi.nlm.nih.gov/pubmed/32726238 http://dx.doi.org/10.5811/westjem.2020.5.47810 |
Ejemplares similares
-
Response to: “Management of Chloroquine and Hydroxychloroquine Poisoning: Do Not Miss the Time of Tracheal Intubation and Mechanical Ventilation”
por: Lebin, Jacob A., et al.
Publicado: (2021) -
Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department
por: Brown, Cortlyn, et al.
Publicado: (2020) -
The Impact of COVID-19 on Healthcare Worker Wellness: A Scoping Review
por: Shreffler, Jacob, et al.
Publicado: (2020) -
Scabies: Application of the Novel Identify-Isolate-Inform Tool for Detection and Management
por: Cheng, Tabitha A., et al.
Publicado: (2020) -
Emergency Department Management of COVID-19: An Evidence-Based Approach
por: McManus, Nicholas M., et al.
Publicado: (2020)